Wed, Aug 31, 2016
Following the FDC ban, this market fell by 3.9% to Rs 234 crore in the given quarter. Whereas drugs under NLEM grew by 1.6% to Rs 1061 crore, while non-NLEM drugs posted growth of 11.2% to Rs 7677 crore.
More >
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.